Clinical Trial Update: Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression

View source ↗

Summary

University of Illinois at Chicago is conducting a trial examining recurrence markers, cognitive burden, and neurobiological homeostasis in late-life depression;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Depression in Old Age, Recurrence | Status: ACTIVE_NOT_RECRUITING